MIRATI
Live / Registered — Registered and renewed (as of 15 Jul 2025)
What this means for you
Registered since 31 Mar 2015. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 31 Mar 2025).
Record
- Serial number
- 86363098
- Registration number
- 4712007
- Mark type
- Stylized text
- Filed
- 11 Aug 2014
- Published for opposition
- 13 Jan 2015
- Registered
- 31 Mar 2015
- Next maintenance due
- 31 Mar 2025
- Attorney of record
- Marilyn F. Kelly
Goods and services
- Class 042 — Scientific and technological services: research and development of pharmaceuticals in the field of oncology; providing information in the field of scientific and medical research related to oncology
Owner
- Mirati Therapeutics, Inc., San Diego, CA, US
- Mirati Therapeutics, Inc., San Diego, CA, US
- Mirati Therapeutics, Inc., San Diego, CA, US
Prosecution history
- 15 Jul 2025 — NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
- 15 Jul 2025 — REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
- 15 Jul 2025 — REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
- 15 Jul 2025 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 14 Feb 2025 — TEAS SECTION 8 & 9 RECEIVED
- 25 Jun 2024 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 25 Jun 2024 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 25 Jun 2024 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 31 Mar 2024 — COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
- 22 Jun 2021 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 22 Jun 2021 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 21 Jun 2021 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 10 Feb 2021 — TEAS SECTION 8 & 15 RECEIVED
- 31 Mar 2020 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 04 Feb 2020 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED